OP
OPADW
Offerpad Solutions Inc.
No data for this timeframe.
Vol
Market Cap$25.6M
Cap SizeNano Cap
SEC Reports4
Recent Activity
Apr 30, 2026
SEC
Offerpad Solutions filed a prospectus supplement on April 30, 2026, to sell up to $69,738,969 of Class A common stock un
8-K — Impact 3/10
Apr 30, 2026
SEC
Offerpad Solutions filed a prospectus supplement (424B5) to register the remaining $69.7 million of its $100 million at-
424B5 — Impact 7/10
Apr 27, 2026
SEC
Offerpad Solutions filed a pre-effective amendment (S-3/A) solely to include an updated consent from its independent aud
S-3/A — Impact 2/10
Latest Reports
NEUTRAL
8-K
3/10
Offerpad Solutions filed a prospectus supplement on April 30, 2026, to sell up to $69,738,969 of Class A common stock un
Apr 30, 2026
BEARISH
424B5
7/10
Offerpad Solutions filed a prospectus supplement (424B5) to register the remaining $69.7 million of its $100 million at-
Apr 30, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 3 neutral. Avg impact: 4.0/10.
NEUTRAL
8-K
3/10
Offerpad Solutions filed a prospectus supplement on April 30, 2026, to sell up to $69,738,969 of Cla
Apr 30, 2026
BEARISH
424B5
7/10
Offerpad Solutions filed a prospectus supplement (424B5) to register the remaining $69.7 million of
Apr 30, 2026
NEUTRAL
S-3/A
2/10
Offerpad Solutions filed a pre-effective amendment (S-3/A) solely to include an updated consent from
Apr 27, 2026
NEUTRAL
DEFA14A
4/10
Offerpad Solutions Inc. is holding its 2026 Annual Meeting to vote on several proposals, including t
Apr 22, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | -46.9% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | -12.9% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.4B | -27.5% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.6B | 35.1% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.